Phase 2 biotech developing therapies for CNS disorders using genetic insights.
Industry: Health Care
First Day Return: +46.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/25/2020 |
Offer Price | $19.00 |
Price Range $17.00 - $18.00 | |
Offer Shares (mm) | 10.0 |
Deal Size ($mm) | $190 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/15/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $190 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2015 |
Employees at IPO | 51 |
Website www.praxismedicines.com |